Severe rhabdomyolysis following a seizure as a manifestation of McArdle disease: a case report
Abstract
Case Presentation: A previously healthy male patient presented at the age of 18 with his first generalized tonic–clonic seizure, evolving with severe rhabdomyolysis, acute kidney injury, and the need for hemodialysis. Treatment with oxcarbazepine was initiated; however, seizures recurred in 2019 and in 2022. In the most recent episode, creatine phosphokinase (CPK) levels were initially unmeasurable and later measured at 150,000 U/L, associated with elevated transaminases and hyperkalemia. He was managed in the intensive care unit without the need for further hemodialysis, maintaining a good overall clinical status that was disproportionate to the severity of rhabdomyolysis. Brain magnetic resonance imaging and electroencephalography were unremarkable. Electroneuromyography showed a nonspecific myopathic pattern. Further investigation included an expanded genetic panel for neuromuscular disorders, which identified two pathogenic heterozygous variants in the PYGM gene (p.Arg50* and p.Val456Met), consistent with the diagnosis of McArdle disease. Oxcarbazepine was replaced with levetiracetam, and the patient has remained seizure-free since 2022. Discussion: McArdle disease (glycogen storage disease type V) is a rare metabolic myopathy caused by deficiency of the enzyme myophosphorylase, characterized by exercise intolerance, myalgia, cramps, and recurrent episodes of rhabdomyolysis. Symptom onset typically occurs in childhood or adolescence, and chronically elevated creatine phosphokinase (CPK) levels are common. Presentation with seizures is not part of the classical clinical spectrum of the disease, and its occurrence is therefore considered an independent comorbidity. The epileptic seizure acted as a triggering factor for massive rhabdomyolysis, prompting diagnostic investigation and subsequent identification of the underlying etiology. There is no evidence of a causal relationship between epilepsy and McArdle disease. In this context, rhabdomyolysis is interpreted as resulting from impaired glycogenolysis, leading to energy failure during acute muscular stress. Recognition of persistently elevated CPK levels was crucial in guiding the diagnostic hypothesis toward a metabolic myopathy. Final Comments: This case underscores the importance of considering the diagnosis in the presence of chronically elevated CPK levels associated with rhabdomyolysis. Although no disease-modifying therapy exists for McArdle disease, appropriate management—including guidance on physical activity, carbohydrate intake before exertion, and avoidance of triggers—is essential. In addition, seizure control was crucial to prevent new episodes and complications, particularly acute kidney injury.